KD Logo

Needham analysts initates a Buy rating for Hims & Hers Health Inc (HIMS)

Hims & Hers Health Inc’s filing revealed that its Chief Medical Officer Carroll Patrick Harrison unloaded Company’s shares for reported $0.33 million on Nov 06 ’24. In the deal valued at $22.07 per share,15,000 shares were sold. As a result of this transaction, Carroll Patrick Harrison now holds 196,941 shares worth roughly $5.49 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Chi Michael sold 2,054 shares, generating $45,188 in total proceeds. Upon selling the shares at $22.00, the Chief Commercial Officer now owns 193,980 shares.

Before that, Dudum Andrew sold 188,888 shares. Hims & Hers Health Inc shares valued at $3,944,578 were divested by the Chief Executive Officer at a price of $20.88 per share. As a result of the transaction, Dudum Andrew now holds 67,015 shares, worth roughly $1.87 million.

Needham initiated its Hims & Hers Health Inc [HIMS] rating to a Buy in a research note published on August 22, 2024; the price target was $24. A number of analysts have revised their coverage, including Imperial Capital’s analysts, who decreased its forecast for the stock in early August from “an Outperform” to “an In-line”. Citigroup also remained covering HIMS and has decreased its forecast on May 22, 2024 with a “Neutral” recommendation from previously “Buy” rating. Jefferies revised its rating on April 16, 2024. It rated HIMS as “a Hold” which previously was an “a Buy”.

Price Performance Review of HIMS

On Monday, Hims & Hers Health Inc [NYSE:HIMS] saw its stock jump 19.09% to $27.88. Over the last five days, the stock has gained 34.30%. Hims & Hers Health Inc shares have risen nearly 213.26% since the year began. Nevertheless, the stocks have risen 320.51% over the past one year. While a 52-week high of $25.74 was reached on 11/11/24, a 52-week low of $6.58 was recorded on 01/05/24. SMA at 50 days reached $19.01, while 200 days put it at $16.78.

Levels Of Support And Resistance For HIMS Stock

The 24-hour chart illustrates a support level at 24.95, which if violated will result in even more drops to 22.03. On the upside, there is a resistance level at 30.24. A further resistance level may holdings at 32.61. The Relative Strength Index (RSI) on the 14-day chart is 71.67, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 2.98, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 15.85%. Stochastics %K at 82.49% indicates the stock is a selling.

How much short interest is there in Hims & Hers Health Inc?

A steep rise in short interest was recorded in Hims & Hers Health Inc stocks on 2024-10-15, growing by 5.34 million shares to a total of 31.87 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 26.54 million shares. There was a rise of 16.74%, which implies that there is a positive sentiment for the stock.

The most recent change occurred on April 10, 2024 when Canaccord Genuity began covering the stock and recommended ‘”a Buy”‘ rating along with a $20 price target.

Most Popular